A lower proportion of patients initiating exenatide b.i.d. had microvascular and macrovascular complications (compared with patients initiating insulin), a finding that might reflect their younger mean age, glycemic control (HbA1c), and duration of diabetes. Here, INS is linked to diabetes mellitus.